Grimes & Company’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.76M | Sell |
107,540
-12,396
| -10% | -$1.13M | 0.21% | 83 |
|
|
2026
Q1 | $12.3M | Buy |
119,936
+47,108
| +65% | +$5.32M | 0.34% | 63 |
|
|
2025
Q4 | $9.12M | Buy |
72,828
+2,404
| +3% | +$306K | 0.22% | 82 |
|
|
2025
Q3 | $9.43M | Buy |
70,424
+10,635
| +18% | +$1.4M | 0.23% | 81 |
|
|
2025
Q2 | $8.13M | Buy |
59,789
+814
| +1% | +$107K | 0.22% | 92 |
|
|
2025
Q1 | $7.82M | Buy |
58,975
+851
| +1% | +$108K | 0.24% | 91 |
|
|
2024
Q4 | $6.57M | Buy |
58,124
+179
| +0.3% | +$20.7K | 0.19% | 93 |
|
|
2024
Q3 | $6.61M | Buy |
57,945
+1,188
| +2% | +$130K | 0.18% | 97 |
|
|
2024
Q2 | $5.9M | Sell |
56,757
-219
| -0.4% | -$23.2K | 0.18% | 97 |
|
|
2024
Q1 | $6.48M | Sell |
56,976
-58
| -0.1% | -$6.65K | 0.2% | 94 |
|
|
2023
Q4 | $6.28M | Buy |
57,034
+2,481
| +5% | +$248K | 0.21% | 88 |
|
|
2023
Q3 | $5.28M | Buy |
54,553
+228
| +0.4% | +$23.9K | 0.2% | 90 |
|
|
2023
Q2 | $5.92M | Sell |
54,325
-135
| -0.2% | -$14.4K | 0.21% | 85 |
|
|
2023
Q1 | $5.51M | Buy |
54,460
+20
| +0% | +$2.11K | 0.23% | 84 |
|
|
2022
Q4 | $5.98M | Buy |
54,440
+11
| +0% | +$1.14K | 0.25% | 78 |
|
|
2022
Q3 | $5.27M | Sell |
54,429
-162
| -0.3% | -$17.3K | 0.27% | 75 |
|
|
2022
Q2 | $5.93M | Buy |
54,591
+113
| +0.2% | +$12.8K | 0.3% | 71 |
|
|
2022
Q1 | $6.45M | Buy |
54,478
+14
| +0% | +$1.74K | 0.34% | 75 |
|
|
2021
Q4 | $7.67M | Sell |
54,464
-1,174
| -2% | -$150K | 0.35% | 68 |
|
|
2021
Q3 | $6.57M | Buy |
55,638
+122
| +0.2% | +$15K | 0.29% | 78 |
|
|
2021
Q2 | $6.44M | Sell |
55,516
-98
| -0.2% | -$11.4K | 0.28% | 79 |
|
|
2021
Q1 | $6.67M | Buy |
55,614
+7,975
| +17% | +$945K | 0.32% | 78 |
|
|
2020
Q4 | $5.22M | Hold |
47,639
| – | – | 0.27% | 78 |
|
|
2020
Q3 | $5.18M | Sell |
47,639
-11
| -0% | -$1.12K | 0.33% | 75 |
|
|
2020
Q2 | $4.36M | Buy |
47,650
+59
| +0.1% | +$5.33K | 0.3% | 75 |
|
|
2020
Q1 | $3.75M | Buy |
47,591
+2,003
| +4% | +$167K | 0.34% | 66 |
|
|
2019
Q4 | $3.96M | Buy |
45,588
+158
| +0.3% | +$13.2K | 0.26% | 80 |
|
|
2019
Q3 | $3.8M | Sell |
45,430
-550
| -1% | -$46.7K | 0.27% | 75 |
|
|
2019
Q2 | $3.87M | Buy |
45,980
+161
| +0.4% | +$12.7K | 0.29% | 73 |
|
|
2019
Q1 | $3.66M | Sell |
45,819
-39
| -0.1% | -$2.9K | 0.29% | 78 |
|
|
2018
Q4 | $3.32M | Sell |
45,858
-95
| -0.2% | -$6.68K | 0.32% | 69 |
|
|
2018
Q3 | $3.37M | Sell |
45,953
-133
| -0.3% | -$8.73K | 0.27% | 77 |
|
|
2018
Q2 | $2.81M | Buy |
46,086
+750
| +2% | +$45.5K | 0.25% | 81 |
|
|
2018
Q1 | $2.72M | Buy |
45,336
+11,138
| +33% | +$671K | 0.26% | 83 |
|
|
2017
Q4 | $1.95M | Buy |
34,198
+30,186
| +752% | +$1.67M | 0.19% | 90 |
|
|
2017
Q3 | $214K | Buy |
+4,012
| New | +$201K | 0.02% | 190 |
|
Other funds holding ABT
WT
RG
DC
ATO
MMC
Grimes & Company's ABT Position: Q2 2026 in Review
Grimes & Company reduced its Abbott (ABT) stake by 10% in Q2 2026, selling an estimated $1.13M and leaving 107,540 shares worth $9.76M. The position accounts for 0.21% of the portfolio, ranked #83.
Grimes & Company first reported a position in ABT in Q3 2017 and has held it in 36 quarters since. The position peaked at $12.3M in Q1 2026. 1,311 funds tracked by Wall St. Rank hold ABT as of Q2 2026.
- Grimes & Company held 107,540 shares of Abbott worth $9.76M as of Q2 2026.
- Grimes & Company sold 12,396 Abbott shares in Q2 2026, an estimated $1.13M.
- Abbott made up 0.21% of Grimes & Company's portfolio in Q2 2026, its #83 holding.
- Grimes & Company first reported a position in Abbott in Q3 2017 and has held it in 36 quarters since.
- Grimes & Company's Abbott position peaked at $12.3M in Q1 2026.
- 1,311 funds tracked by Wall St. Rank held Abbott as of Q2 2026.
Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.